Prophylactic salpingo-oophorectomy reduces the penetrance of ovarian/fallopian tube cancer by 75–96% and breast cancer by 56% (25) in patients with the BRCA1 mutation. This evidence concerns the gene BRCA1 and breast carcinoma.